Accolades
Sidley Deal Honored at D CEO Mergers & Acquisitions Awards
May 14, 2024
Avantax’s US$1.2 billion take-private sale to Cetera won “Deal of the Year” in the $1 Billion + category at D CEO’s Mergers & Acquisitions Awards 2024. Sidley represented Avantax, Inc. (NASDAQ:AVTA), a leader in tax-focused financial planning and wealth management, in its acquisition by Aretec Group, Inc., d/b/a Cetera Holdings, the holding company of Cetera, a financial adviser Wealth Hub. Under the terms of the agreement, holders of Avantax common stock received US$26.00 in cash per share, without interest and subject to required withholding taxes. The all-cash transaction closed in November 2023. The Sidley deal team was led by M&A partners Beth E. Berg and Scott R. Williams.
Additionally, Bill Howell, a partner in Sidley’s Dallas office, was a finalist for “Attorney of the Year” at D CEO’s Mergers & Acquisitions Awards 2024. The annual Mergers & Acquisitions Awards, now in their 11th year, honor the “top acquisitions, dispositions, and other financial transactions in North Texas in 2023 - and the dealmakers who made them happen.”
Additionally, Bill Howell, a partner in Sidley’s Dallas office, was a finalist for “Attorney of the Year” at D CEO’s Mergers & Acquisitions Awards 2024. The annual Mergers & Acquisitions Awards, now in their 11th year, honor the “top acquisitions, dispositions, and other financial transactions in North Texas in 2023 - and the dealmakers who made them happen.”
連絡先
Offices
得意分野
Suggested News & Insights
Sidley Represents NextCure in Merger With Avere Therapeutics and Concurrent US$320 Million Private PlacementJuly 17, 2026Sidley Finishes H1 2026 Among Top Three US$1B+ Dealmakers in TexasJuly 16, 2026European Commission Signals Targeted Procedural Simplification of the Foreign Subsidies Regulation – Without Weakening EnforcementJuly 16, 2026Inspection Rights, Internal Affairs, and Personal Jurisdiction: Orchid Global’s Procedural LessonJuly 15, 2026Sidley Advises EMZ Partners on Its Significant Minority Investment in Steinbach & VollmannJuly 13, 2026Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


